FlandersBio on Twitter

Follow us on Twitter

Archive for August 2011 - News

Archive for August 2011 - Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

Devgen reports half year results 2011

28.08.2011

Devgen nv (Euronext Brussels: DEVG), announced today its results for the six month period ending 30 June 2011. read more

Ablynx announces half year 2011 results

26.08.2011

Ablynx [Euronext Brussels: ABLX] today announced its results for the six-month period ending 30 June 2011, which have been prepared in accordance with the IAS 34 Interim Financial Reporting as adopted by the European Union, and highlighted the developments in its product pipeline and partnerships. read more

TiGenix Gives Business Update & Reports Financial Highlights for the First Half of 2011

26.08.2011

TiGenix NV (NYSE Euronext: TIG) gives an update of its business activities and provides the financial highlights for the half year ending June 30, 2011. read more

Verbeterde diagnose en behandeling van herpespatiënten door nieuwe krachtigere moleculaire tests

25.08.2011

Clinici beschikken voortaan over een nieuw hulpmiddel bij het stellen van een diagnose en het behandelen van patiënten besmet met het Herpes simplex-virus (HSV) – één van de meest gangbare seksueel overdraagbare aandoeningen ter wereld. read more

BD Biosciences introduceert nieuwe celanalysator voor het stroomlijnen van de onderzoeksworkflow

25.08.2011

BD Biosciences, een onderdeel van BD (Becton, Dickinson and Company), heeft vandaag de BD FACSVerse™-flowcytometer geïntroduceerd. Dit is een flexibel, betrouwbaar en schaalbaar systeem dat maximaal 10 parameters kan analyseren en voor een groot aantal onderzoekstoepassingen kan worden gebruikt. read more

MDxHealth Reports 2011 Half-Year Results

25.08.2011

MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized medicine, announced today its 2011 half-year results. read more

ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on ophthalmic medicine, today issued a business update and its financial results for the six months ending 30 June, 2011.

25.08.2011

ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on ophthalmic medicine, today issued a business update and its financial results for the six months ending 30 June, 2011. read more

PNB ready to enter Phase III development with PNB01 in Major Depression

23.08.2011

Pharmaneuroboost (PNB) reported today that it received clearance from the Institutional Review Board (IRB) to initiate its first phase III study with PNB01 in the USA. read more

Road block as a new strategy for the treatment of Alzheimer’s

22.08.2011

Two main agents involved in the inception of Alzheimer's disease (APP and beta secretase) follow a different path through the brain cells to meet up, write Wim Annaert and colleagues of VIB and K.U.Leuven in PNAS. read more

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top

Print